Home › Funds › Siren, L.L.C. › DMRA

Siren, L.L.C. position in DMRA

Damora Therapeutics Inc · Health Care

Siren, L.L.C. reported holding 900,000 shares of DMRA (Damora Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$19.2M, representing 0.45% of its reported portfolio and ranking #50 among its reported holdings. Siren, L.L.C. has disclosed DMRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)900.00K sh
Reported value held$19.15M
Portfolio Weight0.45%
First reportedQ1 2026
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s DMRA position evolved

Siren, L.L.C. first disclosed a stake in DMRA in Q1 2026 at 900,000 shares (US$23.3M). The position peaked in Q2 2026 at 900,000 shares, worth US$23.4M. Across 3 filings, Siren, L.L.C. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 900,000 shares valued at US$19.2M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 900.00K $23.31M New
Q2 2026 900.00K $23.41M Hold
Q3 2026 900.00K $19.15M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMRA and 13F data

DMRA (Damora Therapeutics Inc) is a Health Care company. 106 other funds we track also report a position in DMRA — the largest reported positions include Fairmount Funds Management LLC (US$226.6M), Avoro Capital Advisors LLC (US$98.4M), Venrock Adviser, LLC (US$93.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMRA

All DMRA fund holders →

FAQ

How long has Siren, L.L.C. held DMRA?

Siren, L.L.C. has disclosed DMRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Siren, L.L.C.'s current position in DMRA?

As of Q3 2026, Siren, L.L.C. holds 900.00K shares of DMRA (Damora Therapeutics Inc), valued at $19.15M, representing 0.45% of its reported portfolio and ranking #50.

Has Siren, L.L.C. been buying or selling DMRA?

In the latest 13F filing (Q3 2026), Siren, L.L.C. held unchanged its position in DMRA. The position peaked in Q2 2026 at 900.00K shares.

Which other funds hold DMRA?

Other major institutional holders of DMRA include Fairmount Funds Management LLC, Avoro Capital Advisors LLC, Venrock Adviser, LLC, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.